Jill C. Fehrenbacher, PhD - Publications

Affiliations: 
Pharmacology and Toxicology Indiana University School of Medicine, Indianapolis, IN, United States 
Area:
pain, neurotrophins, estradiol, estrogen

32/49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Iadarola MJ, Sapio MR, Loydpierson AJ, Mervis CB, Fehrenbacher JC, Vasko MR, Maric D, Eisenberg DP, Nash TA, Kippenhan JS, Garvey MH, Mannes AJ, Gregory MD, Berman KF. Syntaxin1A overexpression and pain insensitivity in individuals with 7q11.23 duplication syndrome. Jci Insight. PMID 38261410 DOI: 10.1172/jci.insight.176147  0.564
2022 Behrouzi A, Xia H, Thompson EL, Kelley MR, Fehrenbacher JC. Oxidative DNA Damage and Cisplatin Neurotoxicity Is Exacerbated by Inhibition of OGG1 Glycosylase Activity and APE1 Endonuclease Activity in Sensory Neurons. International Journal of Molecular Sciences. 23. PMID 35163831 DOI: 10.3390/ijms23031909  0.363
2022 Cunningham GM, Shen F, Wu X, Cantor EL, Gardner L, Philips S, Jiang G, Bales CL, Tan Z, Liu Y, Wan J, Fehrenbacher JC, Schneider BP. The impact of SBF2 on taxane-induced peripheral neuropathy. Plos Genetics. 18: e1009968. PMID 34986146 DOI: 10.1371/journal.pgen.1009968  0.325
2021 McCarson KE, Fehrenbacher JC. Models of Inflammation: Carrageenan- or Complete Freund's Adjuvant (CFA)-Induced Edema and Hypersensitivity in the Rat. Current Protocols. 1: e202. PMID 34314105 DOI: 10.1002/cpz1.202  0.343
2020 Cunningham G, Cantor E, Wu X, Shen F, Jiang G, Philips S, Bales C, Xiao Y, Cummins TR, Fehrenbacher JC, Schneider BP. Abstract P5-07-09: Modeling taxane-induced peripheral neuropathy ex vivo using patient-derived neurons Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P5-07-09  0.462
2019 Staff NP, Fehrenbacher JC, Caillaud M, Damaj MI, Segal RA, Rieger S. Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems. Experimental Neurology. 113121. PMID 31758983 DOI: 10.1016/J.Expneurol.2019.113121  0.415
2019 Sun S, Diggins NH, Gunderson ZJ, Fehrenbacher JC, White FA, Kacena MA. No pain, no gain? The effects of pain-promoting neuropeptides and neurotrophins on fracture healing. Bone. 115109. PMID 31715336 DOI: 10.1016/J.Bone.2019.115109  0.357
2018 Kelley MR, Messmann RA, Fehrenbacher J. Novel first-in-class small molecule targeting APE1/Ref-1 to prevent and treat chemotherapy-induced peripheral neuropathy (CIPN). Journal of Clinical Oncology. 36: 229-229. DOI: 10.1200/Jco.2018.36.34_Suppl.229  0.394
2018 Shah FL, Atallah N, Grimard M, Guo C, Zhang C, Fehrenbacher J, Kelley MR, Fishel M. Abstract 4802: Combination therapy in PDAC involving blockade of the APE1/Ref-1 signaling pathway: An investigation into drug synthetic lethality and anti-neuropathy therapeutic approach Cancer Research. 78: 4802-4802. DOI: 10.1158/1538-7445.Am2018-4802  0.357
2017 Fehrenbacher JC, Guo C, Kelley MR, Vasko MR. DNA damage mediates changes in neuronal sensitivity induced by the inflammatory mediators, MCP-1 and LPS, and can be reversed by enhancing the DNA repair function of APE1. Neuroscience. PMID 28965839 DOI: 10.1016/J.Neuroscience.2017.09.039  0.671
2017 Darby LM, Meng H, Fehrenbacher JC. Paclitaxel inhibits the activity and membrane localization of PKCα and PKCβI/II to elicit a decrease in stimulated calcitonin gene-related peptide release from cultured sensory neurons. Molecular and Cellular Neurosciences. PMID 28404507 DOI: 10.1016/j.mcn.2017.04.001  0.539
2016 Malty RH, Hudmon A, Fehrenbacher JC, Vasko MR. Long-term exposure to PGE2 causes homologous desensitization of receptor-mediated activation of protein kinase A. Journal of Neuroinflammation. 13: 181. PMID 27400965 DOI: 10.1186/S12974-016-0645-0  0.663
2016 Duarte DB, Vasko MR, Fehrenbacher JC. Models of Inflammation: Carrageenan Air Pouch. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. 72: 5.6.1-9. PMID 26995549 DOI: 10.1002/0471141755.ph0506s72  0.602
2016 Pittman SK, Gracias NG, Fehrenbacher JC. Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons. Experimental Neurology. PMID 26883566 DOI: 10.1016/J.Expneurol.2016.02.010  0.749
2015 Fehrenbacher JC. Chemotherapy-induced peripheral neuropathy. Progress in Molecular Biology and Translational Science. 131: 471-508. PMID 25744683 DOI: 10.1016/bs.pmbts.2014.12.002  0.361
2015 Fehrenbacher JC, Bingener J, Aho JM, Wasky PR, Locke EE, Schwesinger WH, Van Sickle KR, Hargreaves KM. Men with acute cholecystitis have higher tissue-based cytokine levels than women: A cross-sectional study Chirurgia (Turin). 28: 49-53.  0.4
2014 Chen X, Sun W, Gianaris NG, Riley AM, Cummins TR, Fehrenbacher JC, Obukhov AG. Furanocoumarins are a novel class of modulators for the transient receptor potential vanilloid type 1 (TRPV1) channel. The Journal of Biological Chemistry. 289: 9600-10. PMID 24569998 DOI: 10.1074/Jbc.M113.536862  0.376
2014 Pittman SK, Gracias NG, Vasko MR, Fehrenbacher JC. Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture. Experimental Neurology. 253: 146-53. PMID 24374060 DOI: 10.1016/J.Expneurol.2013.12.011  0.73
2012 Duarte DB, Vasko MR, Fehrenbacher JC. Models of inflammation: carrageenan air pouch. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit5.6. PMID 22383000 DOI: 10.1002/0471141755.ph0506s56  0.599
2012 Fehrenbacher JC, Vasko MR, Duarte DB. Models of inflammation: Carrageenan- or complete Freund's Adjuvant (CFA)-induced edema and hypersensitivity in the rat. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit5.4. PMID 22382999 DOI: 10.1002/0471141755.ph0504s56  0.654
2011 Brittain JM, Duarte DB, Wilson SM, Zhu W, Ballard C, Johnson PL, Liu N, Xiong W, Ripsch MS, Wang Y, Fehrenbacher JC, Fitz SD, Khanna M, Park CK, Schmutzler BS, et al. Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex. Nature Medicine. 17: 822-9. PMID 21642979 DOI: 10.1038/Nm.2345  0.671
2011 Khanna R, Brittain J, Duarte D, Wilson S, Zhu W, Ballard C, Johnson P, Liu N, Xiong W, Ripsch M, Wang Y, Fehrenbacher J, Khanna M, Park C, Brustovetsky N, et al. Suppression of inflammatory and neuropathic pain by uncoupling collapsin response mediator protein 2 (CRMP-2) from the presynaptic calcium channel complex F1000research. 2. DOI: 10.7490/F1000Research.1089589.1  0.603
2010 Park KA, Fehrenbacher JC, Thompson EL, Duarte DB, Hingtgen CM, Vasko MR. Signaling pathways that mediate nerve growth factor-induced increase in expression and release of calcitonin gene-related peptide from sensory neurons. Neuroscience. 171: 910-23. PMID 20870010 DOI: 10.1016/J.Neuroscience.2010.09.027  0.764
2009 Fehrenbacher JC, Sun XX, Locke EE, Henry MA, Hargreaves KM. Capsaicin-evoked iCGRP release from human dental pulp: a model system for the study of peripheral neuropeptide secretion in normal healthy tissue. Pain. 144: 253-61. PMID 19428185 DOI: 10.1016/j.pain.2009.03.027  0.617
2009 Fehrenbacher JC, Loverme J, Clarke W, Hargreaves KM, Piomelli D, Taylor BK. Rapid pain modulation with nuclear receptor ligands. Brain Research Reviews. 60: 114-24. PMID 19162071 DOI: 10.1016/J.Brainresrev.2008.12.019  0.619
2009 Buck L, Fehrenbacher JC, Hargreaves K, Schwesinger WH, Van Sickle K, Bingener J. M1525 Tissue Cytokines Reveal Gender Difference in Acute Cholecystitis Gastroenterology. 136: A-889. DOI: 10.1016/S0016-5085(09)64107-X  0.488
2008 Jeske NA, Diogenes A, Ruparel NB, Fehrenbacher JC, Henry M, Akopian AN, Hargreaves KM. A-kinase anchoring protein mediates TRPV1 thermal hyperalgesia through PKA phosphorylation of TRPV1. Pain. 138: 604-16. PMID 18381233 DOI: 10.1016/j.pain.2008.02.022  0.726
2008 Fehrenbacher J, Hargreaves K, Rodriguez LJ, Schwesinger WH, Sirinek K, Van Sickle K, Olivarri S, Lopez P, Bingener J. QS271. Men Exhibit Markedly Increased Tissue Level Cytokines in Acute Cholecystitis Journal of Surgical Research. 144: 374-375. DOI: 10.1016/j.jss.2007.12.521  0.491
2006 Patwardhan AM, Diogenes A, Berg KA, Fehrenbacher JC, Clarke WP, Akopian AN, Hargreaves KM. PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor. Pain. 125: 114-24. PMID 16781076 DOI: 10.1016/j.pain.2006.05.007  0.749
2006 Zhang YH, Fehrenbacher JC, Vasko MR, Nicol GD. Sphingosine-1-phosphate via activation of a G-protein-coupled receptor(s) enhances the excitability of rat sensory neurons. Journal of Neurophysiology. 96: 1042-52. PMID 16723416 DOI: 10.1152/jn.00120.2006  0.668
2005 Fehrenbacher JC, Burkey TH, Nicol GD, Vasko MR. Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells. Pain. 113: 113-22. PMID 15621371 DOI: 10.1016/j.pain.2004.09.031  0.607
2003 Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain. 105: 133-41. PMID 14499429 DOI: 10.1016/S0304-3959(03)00173-8  0.645
Low-probability matches (unlikely to be authored by this person)
2020 McVeigh LG, Perugini AJ, Fehrenbacher JC, White FA, Kacena MA. Assessment, Quantification, and Management of Fracture Pain: from Animals to the Clinic. Current Osteoporosis Reports. PMID 32827293 DOI: 10.1007/S11914-020-00617-Z  0.265
2017 Kelley MR, Fehrenbacher JC. Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage. Neural Regeneration Research. 12: 72-74. PMID 28250749 DOI: 10.4103/1673-5374.198986  0.258
2019 McVeigh LG, Babu DSP, Blosser RJ, Thompson EL, Fehrenbacher JC, White FA, Kacena MA. Thrombopoietin: Role in Fracture Healing and Pain Proceedings of Imprs. 2. DOI: 10.18060/23537  0.236
2021 Fehrenbacher JC, McCarson KE. Models of Inflammation: Carrageenan Air Pouch. Current Protocols. 1: e183. PMID 34370402 DOI: 10.1002/cpz1.183  0.211
2022 Behrouzi A, Kelley MR, Fehrenbacher JC. Oxidative DNA Damage: A Role in Altering Neuronal Function. Journal of Cellular Signaling. 3: 160-166. PMID 36204460 DOI: 10.33696/signaling.3.079  0.142
2017 Shah F, Logsdon D, Messmann RA, Fehrenbacher JC, Fishel ML, Kelley MR. Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic. Npj Precision Oncology. 1. PMID 28825044 DOI: 10.1038/s41698-017-0023-0  0.126
2006 Fehrenbacher J. (676) The Journal of Pain. 7: S24. DOI: 10.1016/j.jpain.2006.01.078  0.12
2021 Mijit M, Caston R, Gampala S, Fishel ML, Fehrenbacher J, Kelley MR. APE1/Ref-1 - One Target with Multiple Indications: Emerging Aspects and New Directions. Journal of Cellular Signaling. 2: 151-161. PMID 34557865  0.106
2024 Morris AJ, Parker RS, Nazzal MK, Natoli RM, Fehrenbacher JC, Kacena MA, White FA. Cracking the Code: The Role of Peripheral Nervous System Signaling in Fracture Repair. Current Osteoporosis Reports. PMID 38236511 DOI: 10.1007/s11914-023-00846-y  0.094
2024 Nazzal MK, Morris AJ, Parker RS, White FA, Natoli RM, Kacena MA, Fehrenbacher JC. Do Not Lose Your Nerve, Be Callus: Insights Into Neural Regulation of Fracture Healing. Current Osteoporosis Reports. PMID 38294715 DOI: 10.1007/s11914-023-00850-2  0.089
2024 Wang HS, Karnik SJ, Margetts TJ, Plotkin LI, Movila A, Fehrenbacher JC, Kacena MA, Oblak AL. Mind Gaps and Bone Snaps: Exploring the Connection Between Alzheimer's Disease and Osteoporosis. Current Osteoporosis Reports. PMID 38236512 DOI: 10.1007/s11914-023-00851-1  0.06
2024 Nazzal MK, Morris AJ, Parker RS, White FA, Natoli RM, Fehrenbacher JC, Kacena MA. Using AI to Write a Review Article Examining the Role of the Nervous System on Skeletal Homeostasis and Fracture Healing. Current Osteoporosis Reports. PMID 38217755 DOI: 10.1007/s11914-023-00854-y  0.054
2024 Parker RS, Nazzal MK, Morris AJ, Fehrenbacher JC, White FA, Kacena MA, Natoli RM. Role of the Neurologic System in Fracture Healing: An Extensive Review. Current Osteoporosis Reports. PMID 38236509 DOI: 10.1007/s11914-023-00844-0  0.052
2024 Kacena MA, Plotkin LI, Fehrenbacher JC. The Use of Artificial Intelligence in Writing Scientific Review Articles. Current Osteoporosis Reports. PMID 38227177 DOI: 10.1007/s11914-023-00852-0  0.043
2024 Margetts TJ, Wang HS, Karnik SJ, Plotkin LI, Movila A, Oblak AL, Fehrenbacher JC, Kacena MA. From the Mind to the Spine: The Intersecting World of Alzheimer's and Osteoporosis. Current Osteoporosis Reports. PMID 38334917 DOI: 10.1007/s11914-023-00848-w  0.041
2024 Karnik SJ, Margetts TJ, Wang HS, Movila A, Oblak AL, Fehrenbacher JC, Kacena MA, Plotkin LI. Mind the Gap: Unraveling the Intricate Dance Between Alzheimer's Disease and Related Dementias and Bone Health. Current Osteoporosis Reports. PMID 38285083 DOI: 10.1007/s11914-023-00847-x  0.033
2024 Margetts TJ, Karnik SJ, Wang HS, Plotkin LI, Oblak AL, Fehrenbacher JC, Kacena MA, Movila A. Use of AI Language Engine ChatGPT 4.0 to Write a Scientific Review Article Examining the Intersection of Alzheimer's Disease and Bone. Current Osteoporosis Reports. PMID 38225472 DOI: 10.1007/s11914-023-00853-z  0.02
Hide low-probability matches.